-
1
المؤلفون: Jan Sjöberg, Paul C. Lambert, Therese M.-L. Andersson, Paul W. Dickman, Magnus Björkholm, Sandra Eloranta
المصدر: Journal of Clinical Oncology. 31:1435-1441
مصطلحات موضوعية: Adult, Male, Cancer Research, Pediatrics, medicine.medical_specialty, Population, Risk Assessment, Cohort Studies, Young Adult, Sex Factors, Risk Factors, Cause of Death, Humans, Medicine, Registries, Survivors, Mortality, Young adult, education, Survival analysis, Aged, Cause of death, Aged, 80 and over, Sweden, education.field_of_study, business.industry, Age Factors, Middle Aged, Hodgkin Disease, Surgery, Oncology, Cardiovascular Diseases, Population Surveillance, Circulatory system, Hodgkin lymphoma, Female, business, After treatment, Cohort study
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::763c187a943e3f2816ec3d73f6915408Test
https://doi.org/10.1200/jco.2012.45.2714Test -
2
المؤلفون: Åsa Rangert Derolf, Martin Höglund, Ola Landgren, Paul W. Dickman, Therese M.-L. Andersson, Sandra Eloranta, Jan Sjöberg, Malin Hultcrantz, Johan Richter, Magnus Björkholm, Sigurdur Y. Kristinsson, Lotta Ohm
المصدر: Journal of Clinical Oncology. 29:2514-2520
مصطلحات موضوعية: Male, Cancer Research, medicine.medical_treatment, Fusion Proteins, bcr-abl, Hematopoietic stem cell transplantation, Piperazines, Antineoplastic Combined Chemotherapy Protocols, Molecular Targeted Therapy, Young adult, Child, Aged, 80 and over, education.field_of_study, Relative survival, Age Factors, Hematopoietic Stem Cell Transplantation, Myeloid leukemia, Middle Aged, Protein-Tyrosine Kinases, Combined Modality Therapy, Neoplasm Proteins, Leukemia, Treatment Outcome, Oncology, Child, Preschool, Benzamides, Imatinib Mesylate, Female, Adult, medicine.medical_specialty, Adolescent, Population, Antineoplastic Agents, Young Adult, Sex Factors, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Internal medicine, Original Reports, medicine, Humans, Mortality, education, Protein Kinase Inhibitors, Aged, Sweden, business.industry, Infant, medicine.disease, Cancer registry, Pyrimidines, Imatinib mesylate, Immunology, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd7cc27c8bd78736c41d451b5054b3b3Test
https://doi.org/10.1200/jco.2011.34.7146Test